161 related articles for article (PubMed ID: 33856944)
1. Do neurocognitive functions in cannabis induced psychosis groups differ from schizophrenia with cannabis use? A controlled cross-sectional study.
Shah R; Ghosh A; Avasthi A; Nehra R; Ahuja CK; Khandelwal N
Int J Psychiatry Clin Pract; 2021 Sep; 25(3):283-291. PubMed ID: 33856944
[TBL] [Abstract][Full Text] [Related]
2. White Matter Microstructure and Gray Matter Volume in Cannabis-Induced Psychosis and Schizophrenia With Cannabis Use.
Shah R; Ghosh A; Avasthi A; Ahuja CK; Khandelwal N; Nehra R
J Neuropsychiatry Clin Neurosci; 2022; 34(4):406-413. PubMed ID: 35872614
[TBL] [Abstract][Full Text] [Related]
3. Surface-based brain morphometry in schizophrenia vs. cannabis-induced psychosis: A controlled comparison.
Ghosh A; Kaur S; Shah R; Oomer F; Avasthi A; Ahuja CK; Basu D; Nehra R; Khandelwal N
J Psychiatr Res; 2022 Nov; 155():286-294. PubMed ID: 36170756
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive functioning and cannabis use in schizophrenia.
Segev A; Lev-Ran S
Curr Pharm Des; 2012; 18(32):4999-5007. PubMed ID: 22716156
[TBL] [Abstract][Full Text] [Related]
6. Visual scan paths in first-episode schizophrenia and cannabis-induced psychosis.
Benson PJ; Leonards U; Lothian RM; St Clair DM; Merlo MC
J Psychiatry Neurosci; 2007 Jul; 32(4):267-74. PubMed ID: 17653295
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of neurocognition in young psychosis patients with current cannabis use.
Bogaty SER; Lee RSC; Hickie IB; Hermens DF
J Psychiatr Res; 2018 Apr; 99():22-32. PubMed ID: 29407284
[TBL] [Abstract][Full Text] [Related]
8. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
[TBL] [Abstract][Full Text] [Related]
9. Cannabis induced psychosis and subsequent psychiatric disorders.
Shah D; Chand P; Bandawar M; Benegal V; Murthy P
Asian J Psychiatr; 2017 Dec; 30():180-184. PubMed ID: 29096386
[TBL] [Abstract][Full Text] [Related]
10. Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.
Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
Psychopharmacology (Berl); 2016 Mar; 233(5):809-21. PubMed ID: 26621349
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological assessment of memory in child and adolescent first episode psychosis: cannabis and «the paradox effect».
Moreno-Granados JM; Ferrín M; Salcedo-Marín DM; Ruiz-Veguilla M
Rev Psiquiatr Salud Ment; 2014; 7(1):13-24. PubMed ID: 23830215
[TBL] [Abstract][Full Text] [Related]
12. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
Kake TR; Garrett N; Te Aonui M
Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
[TBL] [Abstract][Full Text] [Related]
13. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
[TBL] [Abstract][Full Text] [Related]
14. Does cannabis affect cognitive functioning in patients with schizophrenia?
Rachid H; Saif Z; Raoui S; Serhier Z; Agoub M
Schizophr Res Cogn; 2024 Jun; 36():100299. PubMed ID: 38196922
[TBL] [Abstract][Full Text] [Related]
15. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
16. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
17. The neuropsychological profiles of young psychosis patients with and without current cannabis use.
Bogaty SER; Crouse JJ; Hickie IB; Hermens DF
Cogn Neuropsychiatry; 2019 Jan; 24(1):40-53. PubMed ID: 30621505
[TBL] [Abstract][Full Text] [Related]
18. History of psychosis and previous episodes as potential explanatory factors for neurocognitive impairment in first-treatment bipolar I disorder.
Demmo C; Lagerberg TV; Aminoff SR; Hellvin T; Kvitland LR; Simonsen C; Andreassen OA; Melle I; Ueland T
Bipolar Disord; 2016 Mar; 18(2):136-47. PubMed ID: 26990158
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Neurocognitive Functions in 7-Year-Old Children at Familial High Risk for Schizophrenia or Bipolar Disorder: The Danish High Risk and Resilience Study VIA 7.
Hemager N; Plessen KJ; Thorup A; Christiani C; Ellersgaard D; Spang KS; Burton BK; Gregersen M; Søndergaard A; Greve AN; Gantriis DL; Poulsen G; Seidman LJ; Mors O; Nordentoft M; Jepsen JRM
JAMA Psychiatry; 2018 Aug; 75(8):844-852. PubMed ID: 29926086
[TBL] [Abstract][Full Text] [Related]
20. Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
Mallet J; Ramoz N; Le Strat Y; Gorwood P; Dubertret C
Eur Arch Psychiatry Clin Neurosci; 2017 Oct; 267(7):629-638. PubMed ID: 28190094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
